Articles On Imugene (ASX:IMU)

DroneShield Ltd (ASX: DRO) shares had a sensational start to the week on Monday. The counterdrone technology company's shares jumped 16% to $1.03. Why did DroneShield shares rocket? Investors were scrambling to buy the company's shares foll...

The DroneShield Ltd (ASX: DRO) share price is flying high today. Shares in the S&P/ASX 300 Index (ASX: XKO) drone defence company closed Friday trading for 89 cents. In morning trade on Monday, shares are swapping hands for $1.00 apiece...

Donald Trump exempts “pharmaceuticals” from his tariff blitz ASX device makers mull their US manufacturing plans as Ansell shares plunge Race and Imugene progress their early-stage oncology trials   Liberation Day has spared the pharmaceu...

The DroneShield Ltd (ASX: DRO) share price had a month of ups and downs in March. But the good news for the counter drone technology company's shareholders is that there were more ups than downs. As a result, the company's shares defied the...

The New Hope Corporation Ltd (ASX: NHC) share price is sinking deep into the red on Monday. In morning trade, the coal miner's shares are down 6% to $3.86. Why is the New Hope share price sinking? The good news for shareholders is that tod...

Highlights: ASX market fluctuations bring varied performances across sectors. Health Care and Telecommunications display resilience, while Utilities and Real Estate show a different trajectory. Several ASX-listed companies p...

Highlights: Nanosonics sees market movement following regulatory approval in the United States. Arafura establishes a long-term supply agreement in the rare earth sector. Jatcorp faces market challenges amid international tr...

Good afternoon and welcome to HotCopper’s Market Close for Thursday, I’m Jonathon Davidson. It was another better-looking day for the bourse as the XJO closed above 7,900 points. Looking at sectors, IT took the lead up 2.4% while Mate...

Passive income investors received some welcome news on Tuesday in the form of a big lift in the New Hope Corp Ltd (ASX: NHC) dividend. Shares in the S&P/ASX 200 Index (ASX: XJO) coal stock closed up 8.9% on 18 March, the day the company...

It was a return to red ink for the S&P/ASX 200 Index (ASX: XJO) this Wednesday, as investors lost the steam that had been powering a recovery over the past few trading days. By the time trading w...

Chances are, most ASX investors who buy and sell shares on our markets have never heard of the gold-silver ratio. But if you're a precious metals investor or enthusiast, you've probably heard of this metric. Its use in our modern world is q...

The S&P/ASX 200 Index (ASX: XJO) is having a subdued session on Wednesday. In afternoon trade, the benchmark index is down 0.2% to 7,844 points. Four ASX shares that are not letting that hold them back are listed below. Here's why the...

Highlights: The financial sector leads market gains, while utilities register the biggest decline. Opthea enters voluntary suspension ahead of COAST trial results release. Imugene secures FDA Fast Track Designation for its C...

The selling action dragging the All Ordinaries Index (ASX: XAO) into the red today isn't holding back this surging ASX share. The soaring stock in question is Clover Corp Ltd (ASX: CLV). Shares in the nutritional ingredients company closed...

The ASX has been trading flat at around 7,864 points. Financials has been the best performing sector, up 0.3%, followed by Materials, up 0.15% and Energy, up 0.1%. Utilities has been the worst performer, down 1.1%, followed by Industr...

Emvision to launch remote stroke detection trial It’s a tricky market but biotechs are raising funds Imugene wins FDA fast-track status for cancer program   Ahead of a wider trial, Emvision Medical Devices (ASX:EMV) has taken to the air w...

Imugene Ltd (ASX: IMU) shares are on the move on Wednesday and avoiding the market weakness after the clinical-stage immuno-oncology company announced a major regulatory milestone in the United States. At the time of writing, the ASX stock...

Profit-making ASX biotechs have been caught up in the market rout During Brain Health Week, let’s not forget about dementia risks Argent looks for Malta site deal While few stocks or sectors have escaped the market correction – or almost...

Johns Lyng Group (ASX:JLG) has seen a sharp shares selloff through Monday trade after it was confirmed the insurance repairer would be removed from the ASX 200 when the index reshuffles a little later this month. Listen to the HotCopper...

The S&P/ASX 200 Health Care Index fell 7.66% in February with the S&P/ASX 200 down 3.79% Morgans healthcare analyst Iain Wilkie said several factors caused investor jitters in February including job cuts to US FDA  Pacific Edge was...

Healthcare analysts say Neuren shares should be worth more than double what they are Biotech sector retreats in February, despite some record results Dimerix pockets $3.2 million payment from Japanese partner   Some healthcare analysts be...

Imugene is carrying out three immune-oncology clinical programs that could revolutionise cancer treatment The company could be the first to win approval for an allogeneic (off-the-shelf) CAR-T-based solid cancer drug After a minimum $20 mi...

With so many shares to choose from on the Australian share market, it can be difficult to decide which ones to buy. The good news is that brokers across the country are doing a lot of the hard work for you. Three top ASX shares that leading...

Many ASX sectors, such as ASX gold shares, tech shares and retail shares, have delivered strong returns over the past year or so. As such, many investors may be wondering where to look for buying opportunities. Well, some analysts have i...

High-quality ASX dividend stocks that have fallen significantly in price can be smart buys for income investors. Here, I'll take a look at the business GQG Partners Inc (ASX: GQG) as one that I think looks very appealing right now. The G...

The S&P/ASX 200 Index (ASX: XJO) capped off what has been an exceptional week for ASX shares with another rise (and yet another new record intra-day high ). The ASX 200 finished up at 8,555.8...

The ASX200 has been up 0.5% at 8,582 points. The Aussie index pared early gains as speculation continues to swirl around the RBA’s rate decision due next week. IT and Staples have been the best performing sectors, up 1.5%, followed by...

Highlights • ASX200 fell slightly amid global trade tensions• Some small-cap stocks demonstrate strong financial fundamentals• Leading penny stocks such as ASX:EVO, ASX:LBL, and ASX:EZZ offer diverse prospects The Australian stock mar...

  Percheron has detailed why its Duchenne muscular dystrophy trial flopped – and why it needs to find a new drug candidate Imugene’s multiple oncology and inflammation programs aren’t helping its valuation Impedimed and Micro-X raise funds...

Good afternoon and welcome to HotCopper Highlights for Week 5, I’m Jonathon Davidson. Let’s get into it.  Let’s start at the end of the week. Hotly watched on Friday was uranium player Peninsula Energy’s news its Wyoming-based Lance uran...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin SPI futures suggest another positive session awaits the Australian stock market. W...

Highlights Imugene has received a research and development (R&D) tax refund of AU$11.69 million for FY23. The refund includes interest of AU$514,093. The refund is provided under the Australian Government’s R&D tax incentive....

Although under pressure today, the All Ordinaries Index (ASX: XAO) is up 1.3% so far in 2025, with three ASX All Ords shares racing ahead of those gains. At market close yesterday, these three companies were leading the charge higher in...

The S&P/ASX 200 Health Care Index fell 1.85% in December but rose 7.51% overall in 2024  Mesoblast surged 52% in December after the US FDA approved its cell therapy Ryoncil for treatment of paediatric GvHD Percheron plunged 91% in Dece...

Fickle fashion trends don’t just apply to apparel. While still a hot sector, cell therapies have suffered from hyped-up expectations, clinical setbacks and high development and manufacturing costs. Arovella Therapeutics (ASX:ALA) chief Dr M...

Highlights  Technology and Real Estate sectors showed strong performance, leading market gains.  Materials sector declined sharply, impacted by falling iron ore prices.  West Wits Mining (WWI) surged after a financing update for its S...

ASX flat despite tech rally Uranium miners gain further after Cameco suspends production Canada’s PM Justin Trudeau set to resign amid mounting pressure   The ASX closed flattish on Monday despite a tech rally. The tech sector rose follow...

The Gold Road Resources Ltd (ASX: GOR) share price is on the slide on Monday morning. In early trade, the ASX 200 gold stock is down 1.5% to $2.05 Why is this ASX 200 gold stock falling? Investors have been selling the gold miner's shares t...

The Aussie bourse has defied morning expectations for the second time in as many days, closing out all but flat with a 0.03% rise – again going against what ASX 200 futures had originally first predicted (today being a bigger drop). It w...

It has been a great finish to the week for Paladin Energy Ltd (ASX: PDN) shares. In afternoon trade, the ASX uranium stock is up 7% to $8.46. But this gain isn't even the strongest in the industry today. For example, at the time of writing,...

Mining shares are dominating the top 10 risers of the benchmark S&P/ASX 200 Index (ASX: XJO) today. ASX 200 gold shares and uranium shares feature prominently following lifts in their commodity prices. The S&P/ASX 200 Material...

The S&P/ASX 200 Index (ASX: XJO) is fighting hard to end the week on a positive note. In afternoon trade, the benchmark index is up 0.4% to 8,232.7 points. Four ASX shares that are rising more than most today are listed below. Here's w...

Highlights Imugene has dosed the first Australian patient in its Phase 1b azer-cel clinical trial at Sydney's Royal Prince Alfred Hospital. U.S. cohort results showed three patients achieved complete responses (CR) despite previous tre...

Imugene Limited (ASX:IMU) has hit its first important milestone in 2025, dosing its first Australian patient with its allogenic CAR T-cell therapy Azer-cel treatment at the Royal Prince Alfred Hospital in Sydney earlier this week. This d...

Imugene Ltd (ASX: IMU) shares are ending the week on a positive note. In late morning, trade, the ASX small cap stock is up 5% to 4.1 cents. Why is this ASX small cap stock roaring higher? Investors have been bidding the immuno-oncology com...

I'm a little melancholic this morning. Well, as melancholic as a dyed-in-the-wool optimist can be, anyway. It's the last day of our getaway down the NSW South Coast – in a couple of hours, we'll be packed up and on our way. It's...

The ASX 200 is expected to open 0.07% lower at 8,185 points, though after yesterday’s defiant reversal things may change through morning trade. Futures tipping a drop Down Under comes after the S&P 500 and Nasdaq composite both exten...

S&P/ASX All Ordinaries Index (ASX: XAO) shares rose by 7.55% and delivered total gross returns, including dividends, of 11.44% last year. That's a pleasing overall market return in anyone's language. But for some stockpickers,...

With more than seven million users moving through HotCopper forums every year, there’s always bound to be some fireside chats – and some companies and stocks definitely shaped as more discussed than others in 2024. Buy now, pay later pla...

Of the 2,200 entities listed on the ASX in 2024, ten stood out by quite a distance on the HotCopper forums as the most-watched stocks of the year. From gas to financial brokers, biotech operators to lithium miners, and even a gold antimo...